FP,
the following is blurb on Mr Brian Willoughby Leedman
NSB NEUROSCIENTIFIC
Mr Leedman is a marketing and investor relations professional with over 15 years' experience in the biotechnology industry. Mr Leedman was co-founder of ResApp Diagnostics Pty Ltd which was acquired by Narhex Life Sciences Ltd to form ResApp Health. Prior to ResApp, Mr Leedman co-founded Oncosil Medical Limited and Biolife Science Limited (acquired by Imugene Limited). Mr Leedman previously served for 10 years as Vice President, Investor Relations for pSivida Corp which is listed on the ASX and NASDAQ. During the past three years Mr Leedman has served as a Director of ResApp Health Ltd and Alcidion Group Ltd. He is formerly the WA chairman of AusBiotech, the association of biotechnology companies in Australia.
IMU Price at posting:
2.0¢ Sentiment: Buy Disclosure: Held